Delisting risk
Mereo BioPharma Group (ADR) (MREO)
Advances acquired rare-disease drug candidates through clinical development and partnerships.
$0.2651
Pre-market−0.00 (−0.75%)
At close$0.2671(−3.47%)
Something off on this page? Send us feedback.
Next report
Nov 9, 2026
estimated · in 67 days
EPS estimate
−$0.01
Revenue estimate
$863.8K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.01−$0.02−$0.02−$0.01−$0.01−$0.01−$0.01Pending
Estimate−$0.02−$0.01−$0.01−$0.01−$0.01$0.02−$0.01−$0.01
Surprise+50.0%−100.0%−100.0%−20.0%0.0%−150.0%0.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.3M—$685.7K$300.0K———Pending
Estimate$11.9M$11.9M—$5.3M$23.3M$11.7M$3.5M$863.8K
Surprise−88.8%——−94.3%————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.01 | — | — |
| Aug 2026 | −$0.01 | −$0.01 | 0.0% |
| May 2026 | $0.02 | −$0.01 | −150.0% |
| Mar 2026 | −$0.01 | −$0.01 | 0.0% |
| Nov 2025 | −$0.01 | −$0.01 | −20.0% |
The latest year is open to everyone — the 35 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| Jun 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Jun 2022 | |||
| Apr 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Jun 2020 | |||
| Sep 2019 | |||
| Sep 2019 | |||
| Apr 2019 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | −$0.01 | — | — | $863.8K | — | — | — |
| Aug 11, 2026 | −$0.01 | −$0.01 | 0.0% | $3.5M | — | — | +12.2% |
| May 12, 2026 | $0.02 | −$0.01 | −150.0% | $11.7M | — | — | +5.5% |
| Mar 19, 2026 | −$0.01 | −$0.01 | 0.0% | $23.3M | — | — | −5.2% |
| Nov 10, 2025 | −$0.01 | −$0.01 | −20.0% | $5.3M | $300.0K | −94.3% | +5.7% |
The latest year is open to everyone — the 35 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 26, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 17, 2023 | |||||||
| Sep 7, 2023 | |||||||
| Jun 27, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Apr 1, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Sep 29, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Jun 15, 2020 | |||||||
| Sep 30, 2019 | |||||||
| Sep 17, 2019 | |||||||
| Apr 29, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||